MW 353.35 Da, Purity >98%. GluK1 (formerly GluR5) and GluK3 (formerly GluR7) receptor selective antagonist (Kb =10 nM and IC50 = 23 nM, respectively). IC50 values are >100 μM at recombinant human GLUA2 (formerly GluR2), GluK2 (formerly GluR6,) GluK2/GluK5 (formerly GluR6/KA2) and GluK2/GluK3 (formerly GluR6/GluR7). Selective over native AMPA receptors (Kd = 83 μM) and exhibits no activity at NMDA and Group I mGlu receptors at concentrations of up to 10 μM.
AMPA 1, AMPA-selective glutamate receptor 1, EEA3, Excitatory amino acid receptor 3, Excitatory amino acid receptor 5, GLR 7, GLR5, GLUH1, GRIA1_HUMAN, GRIK1_HUMAN, GRIK3_HUMAN, GluA1, GluR 7a, GluR-1, GluR-5, GluR-6, GluR-7, GluR-A, GluR-K1, Glutamate receptor, Glutamate receptor 1, Glutamate receptor 5, Glutamate receptor 7, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, Glutamate receptor ionotropic kainate 1, Glutamate receptor ionotropic kainate 3, HBGR1, Human glutamate receptor GLUR5, MGC133252, OTTHUMP00000096569, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243, ionotropic kainate 1, ionotropic kainate 3
MW 353.35 Da, Purity >98%. GluK1 (formerly GluR5) and GluK3 (formerly GluR7) receptor selective antagonist (Kb =10 nM and IC50 = 23 nM, respectively). IC50 values are >100 μM at recombinant human GLUA2 (formerly GluR2), GluK2 (formerly GluR6,) GluK2/GluK5 (formerly GluR6/KA2) and GluK2/GluK3 (formerly GluR6/GluR7). Selective over native AMPA receptors (Kd = 83 μM) and exhibits no activity at NMDA and Group I mGlu receptors at concentrations of up to 10 μM.
Soluble in DMSO to 25 mM.
GluK1 (formerly GluR5) and GluK3 (formerly GluR7) receptor selective antagonist (Kb =10 nM and IC50 = 23 nM, respectively). IC50 values are >100 μM at recombinant human GLUA2 (formerly GluR2), GluK2 (formerly GluR6,) GluK2/GluK5 (formerly GluR6/KA2) and GluK2/GluK3 (formerly GluR6/GluR7). Selective over native AMPA receptors (Kd = 83 μM) and exhibits no activity at NMDA and Group I mGlu receptors at concentrations of up to 10 μM.
Glutamate Receptor 1 (AMPA subtype) also known as GRIK3 or GluK3 and GluK1 is an ionotropic glutamate receptor that plays a role in fast synaptic transmission in the central nervous system. This receptor exhibits a molecular mass of ~102 kDa and is widely expressed in the brain particularly in regions involved with cognitive functions like the hippocampus and cerebral cortex. The receptor mediates excitatory neurotransmission by allowing the influx of cations through its channel which gets activated upon binding glutamate a neurotransmitter.
Glutamate Receptor 1 participates in synaptic plasticity and modulating neural communication affecting processes such as learning and memory. As a part of the excitatory postsynaptic mechanisms it forms complexes with other ionotropic receptors such as NMDA receptors to regulate synaptic strength and postsynaptic currents. Through these interactions it adjusts synaptic efficacy which in turn influences neural circuit function and behavior.
Glutamate Receptor 1 interacts closely with the glutamatergic signaling pathway and the synaptic plasticity pathway. These pathways highlight its role in the communication between neurons and the adaptation of synapses important for memory and learning processes. Related proteins such as NMDA receptors assist in the modulation of synaptic activity providing a framework for cross-talk between various glutamate receptor types which ensures fine-tuning of synaptic transmission across neuronal networks.
Aberrations in the function of Glutamate Receptor 1 have connections to neurological conditions such as epilepsy and schizophrenia. Dysregulation of this receptor can lead to altered excitatory signals contributing to the pathophysiology of these disorders. Additionally the receptor has ties with other proteins like the aforementioned NMDA receptors in epilepsy where they collectively influence synaptic overexcitation. Understanding these interactions helps to shed light on therapeutic targets for improving neuropsychiatric conditions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab120168, UBP310, GluK1 and GluK3 selective antagonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com